This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Industry-University Cooperation Foundation Hanyang University, Korea Research Institute of Chemical Technology. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2021
Title: Innovations of Shin Hee Kim in Pharmaceutical Composition
Introduction
Shin Hee Kim is a notable inventor based in Seoul, South Korea. She has made significant contributions to the field of pharmaceuticals, particularly through her innovative work on DUSP1 inhibitors. Her research focuses on developing effective treatments for various diseases, including cancer and depression.
Latest Patents
Shin Hee Kim holds 1 patent for her invention titled "Pharmaceutical composition containing DUSP1 inhibitor." This patent describes a pharmaceutical composition that utilizes a DUSP1 inhibitor to address the limitations of traditional inhibitors that target the active site. The allosteric inhibitory mechanism of her invention is particularly effective in preventing or treating diseases associated with DUSP1 enzymes, such as liver cancer, breast cancer, pancreatic cancer, hepatitis C, and depression. Notably, her DUSP1 inhibitor shows promise in treating depression by directly influencing neuronal growth.
Career Highlights
Throughout her career, Shin Hee Kim has worked with esteemed institutions, including the Korea Research Institute of Chemical Technology and the Industry-University Cooperation Foundation at Hanyang University. Her dedication to research and innovation has positioned her as a key figure in the pharmaceutical industry.
Collaborations
Shin Hee Kim has collaborated with several professionals in her field, including Seong Eon Ryu and Tae Hyun Park. These collaborations have further enhanced her research and contributed to the advancement of pharmaceutical compositions.
Conclusion
Shin Hee Kim's innovative work in developing DUSP1 inhibitors represents a significant advancement in the treatment of various diseases. Her contributions to the pharmaceutical field highlight the importance of research and collaboration in driving medical innovations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile